These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34023004)

  • 1. Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis.
    Arora U; Garg P; Agarwal S; Nischal N; Shalimar ; Wig N
    Lancet Infect Dis; 2021 Dec; 21(12):e399-e406. PubMed ID: 34023004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral hepatitis in persons living with HIV in the post-COVID era.
    Soriano V; Moreno-Torres V; Mendoza C; Corral O; Barreiro P
    AIDS Rev; 2023; 25(1):1-13. PubMed ID: 36952663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.
    Lo Re V; Wang L; Devine S; Baser O; Olufade T
    Clin Infect Dis; 2014 Oct; 59(7):1027-31. PubMed ID: 24944235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of raltegravir in patients with HIV-1 and hepatitis B and/or C virus coinfection.
    Rockstroh J; Teppler H; Zhao J; Sklar P; Harvey C; Strohmaier K; Leavitt R; Nguyen BY
    HIV Med; 2012 Feb; 13(2):127-31. PubMed ID: 21599819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.
    Jafari A; Khalili H; Izadpanah M; Dashti-Khavidaki S
    Expert Opin Drug Saf; 2015 May; 14(5):713-31. PubMed ID: 25813487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-Acting Antiretroviral Therapy in Renal Transplant Recipients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Report of Our Experience and Literature Review.
    Moreno-Ramirez M; Villanego F; Vigara LA; Cazorla JM; Naranjo J; Garcia T; Merino MJ; Mazuecos A
    Transplant Proc; 2020 Mar; 52(2):523-526. PubMed ID: 32035678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatitis B and hepatitis C coinfection: an expert review.
    Zarębska-Michaluk D; Flisiak R; Flisiak-Jackiewicz M
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):1033-1044. PubMed ID: 32579414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
    Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
    BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.
    Weimer LE; Fragola V; Floridia M; Guaraldi G; Ladisa N; Francisci D; Bellagamba R; Degli Antoni A; Parruti G; Giacometti A; Manconi PE; Vivarelli A; D'Ettorre G; Mura MS; Cicalini S; Preziosi R; Sighinolfi L; Verucchi G; Libertone R; Tavio M; Sarmati L; Bucciardini R;
    J Antimicrob Chemother; 2013 Jan; 68(1):193-9. PubMed ID: 22984206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
    Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.
    Chan J; Chung RT
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):147-163. PubMed ID: 28263458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES.
    Butt AA; Yan P; Aslam S; Abou-Samra AB; Sherman KE; Shaikh OS
    Clin Infect Dis; 2020 Jul; 71(3):664-666. PubMed ID: 31840746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the treatment of HIV/HBV and HIV/HCV co-infection.
    Masgala A; Bonovas S; Nikolopoulos GK
    Mini Rev Med Chem; 2012 Aug; 12(9):890-904. PubMed ID: 22530578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.
    Grebely J; Oser M; Taylor LE; Dore GJ
    J Infect Dis; 2013 Mar; 207 Suppl 1(Suppl 1):S19-25. PubMed ID: 23390301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant and immune-escape hepatitis B virus mutants, occult hepatitis B infection and coinfections in public hospital patients from Argentina.
    Delfino CM; Giorgio M; García G; Puch SS; Outon E; Mathet VL
    Virus Genes; 2021 Aug; 57(4):327-337. PubMed ID: 34091827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
    Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
    Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on dual hepatitis B and C infection in Taiwan.
    Liu CJ; Chen PJ; Chen DS; Tseng TC; Kao JH
    J Formos Med Assoc; 2016 May; 115(5):298-305. PubMed ID: 26188762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.